Analysis of Fcgamma receptor IIa (cd32) gene polymorphism and anti-malarial IgG subclass antibodies to asexual blood-stage antigen of Plasmodium falciparum in an unstable malaria endemic area of Iran

Experimental Parasitology

Volumn 134, Issue 1, 2013, Pages 115-121

  Zakeri, Sedigheh ^a   Mashhadi, Rahil ^b   Mehrizi, Akram Abouie ^a   Djadid, Navid Dinparast ^a  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b Khatam University   (Iran)

Author keywords

Antibody response; Fc RIIa gene; Genotype; IgG subclasses; Mild malaria; Polymorphism

Indexed keywords

FC RECEPTOR IIA; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; MEROZOITE SURFACE PROTEIN 1; RECOMBINANT PROTEIN;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNIC GROUP; FC RECEPTOR IIA GENE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CHILD; CHILD, PRESCHOOL; DNA, PROTOZOAN; ENDEMIC DISEASES; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; IMMUNOGLOBULIN G; IRAN; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; PLASMODIUM FALCIPARUM; POLYMORPHISM, GENETIC; RECEPTORS, IGG; YOUNG ADULT;

PLASMODIUM FALCIPARUM;

EID: 84875622950     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2013.02.012     Document Type: Article

References (62)

1. Afsharpad M., Zakeri S., Pirahmadi S., Djadid N.D. Molecular monitoring of Plasmodium falciparum resistance to antimalarial drugs after adoption of sulfadoxine-pyrimethamine plus artesunate as the first line treatment in Iran. Acta Trop. 2012, 121(1):13-18.
2. Aribot G., Rogier C., Sarthou J.L., Trape J.F., Balde A.T., Druilhe P., Roussilhon C. Pattern of immunoglobulin isotype response to Plasmodium falciparum blood-stage antigens in individuals living in a holoendemic area of Senegal (Dielmo, west Africa). Am. J. Trop. Med. Hyg. 1996, 54:449-457.
3. Aucan C., Traore Y., Tall F., Nacro B., Traore-Leroux T., Fumoux F., Rihet P. High immunoglobulin G2 (IgG2) and low IgG4 levels are associated with human resistance to Plasmodium falciparum malaria. Infect. Immun. 2000, 68:1252-1258.
4. Aucan C., Traore Y., Tall F., Fumoux F., Rihet P. Familial correlation of immunoglobulin G subclass responses to Plasmodium falciparum antigens in Burkina Faso. Infect. Immun. 2001, 69:996-1001.
5. Bouharoun-Tayoun H., Druilhe P. Plasmodium falciparum malaria: evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity. Infect. Immun. 1992, 60:1473-1481.
6. Bouharoun-Tayoun H., Oeuvray C., Lunel F., Druilhe P. Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages. J. Exp. Med. 1995, 182(2):409-418.
7. Braga E.M., Barros R.M., Reis T.A., Fontes C.J., Morais C.G., Martins M.S., Krettli A.U. Association of the IgG response to Plasmodium falciparum merozoite protein (C-terminal 19 kD) with clinical immunity to malaria in the Brazilian Amazon region. Am. J. Trop. Med. Hyg. 2002, 66:461-466.
8. Bredius R.G., de Vries C.E., Troelstra A., van Alphen L., Weening R.S., van de Winkel J.G., Out T.A. Phagocytosis of Staphylococcus aureus and Haemophilus influenzae type B opsonized with polyclonal human IgG1 and IgG2 antibodies. Functional hFc gamma RIIa polymorphism to IgG2. J. Immunol. 1993, 151(3):1463-1472.
9. Brouwer K.C., Lal A.A., Mirel L.B., Otieno J., Ayisi J., Van Eijk A.M., Lal R.B., Steketee R., Nahlen B.L., Shi Y.P. Polymorphism of Fc receptor IIa for immunoglobulin G is associated with placental malaria in HIV-1-positive women in western Kenya. J. Infect. Dis. 2004, 190:1192-1198.
10. Carlson J., Helmby H., Hill A.V., Brewster D., Greenwood B.M., Wahlgren M. Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies. Lancet 1990, 336:1457-1460.
11. Cooke G.S., Aucan C., Walley A.J., Segal S., Greenwood B.M., Kwiatkowski D.P., Hill A.V. Association of Fcgamma receptor IIa (CD32) polymorphism with severe malaria in West Africa. Am. J. Trop. Med. Hyg. 2003, 69:565-568.
12. Craandijk J., van Krugten M.V., Verweij C.L., van der Velden U., Loos B.G. Tumor necrosis factor-alpha gene polymorphisms in relation to periodontitis. J. Clin. Periodontol. 2002, 29(1):28-34.
13. Dean, A.G., Sullivan, K.M., Soe, M.M., Open Source Epidemiologic Statistics for Public Health, Version. Updated 20.05.2009. http://www.openepi.com.
14. Ferreira M.U., Kimura E.A., De Souza J.M., Katzin A.M. The isotype composition and avidity of naturally acquired anti-Plasmodium falciparum antibodies: differential patterns in clinically immune Africans and Amazonian patients. Am. J. Trop. Med. Hyg. 1996, 55(3):315-323.
15. Groux H., Gysin J. Opsonization as an effector mechanism in human protection against asexual blood stages of Plasmodium falciparum: functional role of IgG subclasses. Res. Immunol. 1990, 141(6):529-542.
16. Haldane J.B.S. Disease and evolution. Ric. Sci. 1949, 19:68-76.
17. Israelsson E., Vafa M., Maiga B., Lysén A., Iriemenam N.C., Dolo A., Doumbo O.K., Troye-Blomberg M., Berzins K. Differences in Fcgamma receptor IIa genotypes and IgG subclass pattern of anti-malarial antibodies between sympatric ethnic groups in Mali. Malar. J. 2008, 7:175.
18. Jiang X.M., Arepally G., Poncz M., McKenzie S.E. Rapid detection of the Fc gamma RIIA-H/R 131 ligand-binding polymorphism using an allele-specific restriction enzyme digestion (ASRED). J. Immunol. Methods 1996, 199(1):55-59.
19. Kobayashi T., Westerdaal N.A., Miyazaki A., van der Pol W.L., Suzuki T., Yoshie H., van de Winkel J.G., Hara K. Relevance of immunoglobulin G Fc receptor polymorphism to recurrence of adult periodontitis in Japanese patients. Infect. Immun. 1997, 65(9):3556-3560.
20. Kobayashi T., Yamamoto K., Sugita N., van der Pol W.L., Yasuda K., Kaneko S., van de Winkel J.G., Yoshie H. The Fc gamma receptor genotype as a severity factor for chronic periodontitis in Japanese patients. J. Periodontol. 2001, 72(10):1324-1331.
21. Kuwano S.T., Bordin J.O., Chiba A.K., Mello A.B., Figueiredo M.S., Vieira-Filho J.P., Fabron A., Kerbauy J. Allelic polymorphisms of human fcgamma receptor IIa and Fcgamma receptor IIIb among distinct groups in Brazil. Transfusion 2000, 40:1388-1392.
22. Kwiatkowski D.P. How malaria has affected the human genome and what human genetics can teach us about malaria. Am. J. Hum. Genet. 2005, 77:171-192.
23. Lehrnbecher T., Foster C.B., Zhu S., Leitman S.F., Goldin L.R., Huppi K., Chanock S.J. Variant genotypes of the low-affinity Fcgamma receptors in two control populations and a review of low-affinity Fcgamma receptor polymorphisms in control and disease populations. Blood 1999, 94:4220-4232.
24. Mackinnon M.J., Mwangi T.W., Snow R.W., Marsh K., Williams T.N. Heritability of malaria in Africa. PLoS Med. 2005, 2:e340.
25. McGuire W., Hill A.V., Allsopp C.E., Greenwood B.M., Kwiatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 1994, 371:508-511.
26. McGuire W., Knight J.C., Hill A.V., Allsopp C.E., Greenwood B.M., Kwiatkowski D. Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles. J. Infect. Dis. 1999, 179:287-290.
27. Mehrizi A.A., Zakeri S., Salmanian A.H., Sanati M.H., Djadid N.D. Plasmodium falciparum: sequence analysis of the gene encoding the C-terminus region of the merozoite surface protein-1, a potential malaria vaccine antigen, in Iranian clinical isolates. Exp. Parasitol. 2008, 118(3):378-385.
28. Mehrizi A.A., Asgharpour S., Salmanian A.H., Djadid N.D., Zakeri S. IgG subclass antibodies to three variants of Plasmodium falciparum merozoite surface protein-1 (PfMSP-1(19)) in an area with unstable malaria transmission in Iran. Acta Trop. 2011, 119:84-90.
29. Michael, C., 2008. A simple calculator to determine whether observed genotype frequencies are consistent with Hardy-Weinberg equilibrium. Available from: .
30. Nasr A., Iriemenam N.C., Troye-Blomberg M., Giha H.A., Balogun H.A., Osman O.F., Montgomery S.M., ElGhazali G., Berzins K. Fc gamma receptor IIa (CD32) polymorphism and antibody responses to asexual blood-stage antigens of Plasmodium falciparum malaria in Sudanese patients. Scand. J. Immunol. 2007, 66:87-96.
31. Nasr A., Elghazali G., Giha H., Troye-Blomberg M., Berzins K. Interethnic differences in carriage of haemoglobin AS and Fcgamma receptor IIa (CD32) genotypes in children living in eastern Sudan. Acta Trop. 2008, 105:191-195.
32. Nasr A., Iriemenam N.C., Giha H.A., Balogun H.A., Anders R.F., Troye-Blomberg M., ElGhazali G., Berzins K. FcgammaRIIa (CD32) polymorphism and anti-malarial IgG subclass pattern among Fulani and sympatric ethnic groups living in eastern Sudan. Malar. J. 2009, 8:43.
33. Newbold C., Warn P., Black G., Berendt A., Craig A., Snow B., Msobo M., Peshu N., Marsh K. Receptor-specific adhesion and clinical disease in Plasmodium falciparum. Am. J. Trop. Med. Hyg. 1997, 57:389-398.
34. Ntoumi F., Flori L., Mayengue P.I., Matondo Maya D.W., Issifou S., Deloron P., Lell B., Kremsner P.G., Rihet P. Influence of carriage of hemoglobin AS and the Fcγ receptor IIa-R131 allele on levels of immunoglobulin G2 antibodies to Plasmodium falciparum merozoite antigens in Gabonese children. J. Infect. Dis. 2005, 192:1975-1980.
35. Oeuvray C., Theisen M., Rogier C., Trape J.F., Jepsen S., Druilhe P. Cytophilic immunoglobulin responses to Plasmodium falciparum glutamate-rich protein are correlated with protection against clinical malaria in Dielmo. Senegal Infect. Immun. 2000, 68:2617-2620.
36. Omi K., Ohashi J., Patarapotikul J., Hananantachai H., Naka I., Looareesuwan S., Tokunaga K. Absence of association between the Fc gamma receptor IIIA-176F/V polymorphism and the severity of malaria in Thai. Jpn. J. Infect. Dis. 2002, 55:167-169.
37. Ouma C., Keller C.C., Opondo D.A., Were T., Otieno R.O., Otieno M.F., Orago A.S., Ong'Echa J.M., Vulule J.M., Ferrell R.E., Perkins D.J. Association of FCgamma receptor IIA (CD32) polymorphism with malarial anemia and high-density parasitemia in infants and young children. Am. J. Trop. Med. Hyg. 2006, 74:573-577.
38. Ouma C., Were G.T., Otieno M.F., Hittner J.B., Vulule J.M., Martinson J., Ong'echa J.M., Ferrell R.E., Perkins D.J. Haplotypes of IL-10 promoter variants are associated with susceptibility to severe malarial anemia and functional changes in IL-10 production. Hum. Genet. 2008, 124:515-524.
39. Parren P.W., Warmerdam P.A., Boeije L.C., Arts J., Westerdaal N.A., Vlug A., Capel P.J., Aarden L.A., van de Winkel J.G. On the interaction of IgG subclasses with the low affinity Fc gamma RIIa (CD32) on human monocytes, neutrophils, and platelets. Analysis of a functional polymorphism to human IgG2. J. Clin. Invest. 1992, 90(4):1537-1546.
40. Rascu A., Repp R., Westerdaal N.A., Kalden J.R., van de Winkel J.G. Clinical relevance of Fc gamma receptor polymorphisms. Ann. NY Acad. Sci. 1997, 815:282-295.
41. Ringwald P., Peyron F., Lepers J.P., Rabarison P., Rakotomalala C., Razanamparany M., Rabodonirina M., Roux J., Le Bras J. Parasite virulence factors during falciparum malaria: rosetting, cytoadherence, and modulation of cytoadherence by cytokines. Infect. Immun. 1993, 61:5198-5204.
42. Rowe A., Obeiro J., Newbold C.I., Marsh K. Plasmodium falciparum rosetting is associated with malaria severity in Kenya. Infect. Immun. 1995, 63:2323-2326.
43. Salmon J.E., Millard S., Schachter L.A., Arnett F.C., Ginzler E.M., Gourley M.F., Ramsey-Goldman R., Peterson M.G., Kimberly R.P. Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans. J. Clin. Invest. 1996, 97:1348-1354.
44. Sanders L.A., Feldman R.G., Voorhorst-Ogink M.M., de Haas M., Rijkers G.T., Capel P.J., Zegers B.J., van der Winkel J.G. Human immunoglobulinG (IgG) Fc receptor IIA (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils. Infect. Immun. 1995, 63:73-81.
45. Shi Y.P., Nahlen B.L., Kariuki S., Urdahl K.B., McElroy P.D., Roberts J.M., Lal A.A. Fcgamma receptor IIa (CD32) polymorphism is associated with protection of infants against high-density Plasmodium falciparum infection. VII. Asembo Bay Cohort Project. J. Infect. Dis. 2001, 184:107-111.
46. Sinha S., Mishra S.K., Sharma S., Patibandla P.K., Mallick P.K., Sharma S.K., Mohanty S., Pati S.S., Mishra S.K., Ramteke B.K., Bhatt R., Joshi H., Dash A.P., Ahuja R.C., Awasthi S., Venkatesh V., Habib S. Polymorphisms of TNF-enhancer and gene for FcgammaRIIa correlate with the severity of falciparum malaria in the ethnically diverse Indian population. Malar. J. 2008, 7:13.
47. Snounou G., Viriyakosol S., Zhu X.P., Jarra W., Pinheiro L., Do Rosario V.E., Thaithong S., Brown K.N. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol. Biochem. Parasitol. 1993, 61:315-320.
48. Stein M.P., Edberg J.C., Kimberly R.P., Mangan E.K., Bharadwaj D., Mold C., Du Clos T.W. C-reactive protein biniding to FcgammaRIIa on human monocytes and neutrophils is allele specific. J. Clin. Invest. 2000, 105:369-376.
49. Taylor R.R., Allen S.J., Greenwood B.M., Riley E.M. IgG3 antibodies to Plasmodium falciparum merozoite surface protein2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria. Am. J. Trop. Med. Hyg. 1998, 58:406-413.
50. Tebo A.E., Kremsner P.G., Luty A.J. Fcgamma receptor-mediated phagocytosis of Plasmodium falciparum-infected erythrocytes in vitro. Clin. Exp. Immunol. 2002, 130:300-306.
51. Urban B.C., Ferguson D.J., Pain A., Willcox N., Plebanski M., Austyn J.M., Roberts D.J. Plasmodium falciparum-infected erythrocytes modulate the maturation of dendritic cells. Nature 1999, 400:73-77.
52. Urban B.C., Willcox N., Roberts D.J. A role for CD36 in the regulation of dendritic cell function. Proc. Natl. Acad. Sci. USA 2001, 98:8750-8755.
53. van de Winkel J.G., Capel P.J. Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunol. Today 1993, 14:215-221.
54. van der Pol W., van de Winkel J.G. IgG receptor polymorphisms: risk factors for disease. Immunogenetics 1998, 48(3):222-232.
55. Wahlgren M., Berzins K., Perlman P., Person M. Characterisation of the humoural immune response in Plasmodium falciparum malaria. II. IgG subclass levels of anti P. falciparum antibodies in different sera. Clin. Exp. Immunol. 1983, 54:135-142.
56. Warmerdam P.A., van der Winkel J.C., Gosselin E.J., Capel P.J. Molecular basis for a polymorphism of human Fc gamma receptor II (CD32). J. Exp. Med. 1990, 172:19-25.
57. Warmerdam P.A., van de Winkel J.G., Vlug A., Westerdaal N.A., Capel P.J. A single amino acid in the second Ig-like domain of the human Fc gamma receptor II is critical for human IgG2 binding. J. Immunol. 1991, 147(4):1338-1343.
58. Wilson J.N., Rockett K., Jallow M., Pinder M., Sisay-Joof F., Newport M., Newton J., Kwiatkowski D. Analysis of IL-10 haplotypic associations with severe malaria. Genes. Immun. 2005, 6:462-466.
59. World Health Organization, 2011. WHO-GMP Update on Artemisinin Resistance. Available from: http://www.who.int/malaria/arupdate092011.pdf.
60. Zakeri S., Afsharpad M., Raeisi A., Djadid N.D. Prevalence of mutations associated with antimalarial drugs in Plasmodium falciparum isolates prior to the introduction of sulphadoxine-pyrimethamine as first-line treatment in Iran. Malar. J. 2007, 6(1):148.
61. Zakeri S., Afsharpad M., Khazemzadeh Z., Mehdizadeh K., Shabani A., Djadid N.D. Association of pfcrt but not pfmdr1 alleles with chloroquine resistance in Iranian isolates of Plasmodium falciparum. Am. J. Trop. Med. Hyg. 2008, 78(4):633-640.
62. Zakeri S., Mehrizi A.A., Zoghi S., Djadid N.D. Non-variant specific antibody responses to the C-terminal region of merozoite surface protein-1 of Plasmodium falciparum (PfMSP-1(19)) in Iranians exposed to unstable malaria transmission. Malar. J. 2010, 9:257.